1. Home
  2. SPXC vs PTGX Comparison

SPXC vs PTGX Comparison

Compare SPXC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPX Technologies Inc.

SPXC

SPX Technologies Inc.

N/A

Current Price

$179.70

Market Cap

9.7B

Sector

Industrials

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$143.70

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPXC
PTGX
Founded
1912
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.3B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
SPXC
PTGX
Price
$179.70
$143.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
13
Target Price
$245.56
$108.23
AVG Volume (30 Days)
337.0K
454.6K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
18.08
N/A
EPS
2.73
2.35
Revenue
$2,265,100,000.00
N/A
Revenue This Year
$16.07
$874.25
Revenue Next Year
$7.68
N/A
P/E Ratio
$65.88
$61.50
Revenue Growth
14.17
N/A
52 Week Low
$179.62
$57.90
52 Week High
$251.08
$160.81

Technical Indicators

Market Signals
Indicator
SPXC
PTGX
Relative Strength Index (RSI) 32.75 47.68
Support Level N/A $141.95
Resistance Level $225.70 $160.81
Average True Range (ATR) 5.82 5.05
MACD -1.43 -0.99
Stochastic Oscillator 12.29 34.46

Price Performance

Historical Comparison
SPXC
PTGX

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: